Sanara MedTech Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Sanara MedTech Inc. (NASDAQ: SMTI), a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings primarily in the United States. Founded in 2001 and headquartered in Fort Worth, Texas, the company offers CellerateRX Surgical Activated Collagen Powder, a hydrolyzed Type I bovine collagen for surgical, traumatic, and burn wounds; BIASURGE Advanced Surgical Solution, a no-rinse antimicrobial irrigation solution; FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix, both porcine small intestinal submucosa-based products for soft tissue reinforcement; TEXAGEN Amniotic Membrane Allograft, a multilayer barrier for wounds; ALLOCYTE Plus Advanced Viable Bone Matrix, a cellular bone allograft; BiFORM Bioactive Moldable Matrix, an osteoconductive bone graft; ACTIGEN Verified Inductive Bone Matrix, a differentiated allograft; BIAKŌS Antimicrobial Skin and Wound Cleanser, Gel, and Irrigation Solution; and HYCOL Hydrolyzed Collagen for chronic wound care. Sanara MedTech recently secures a $55 million non-dilutive debt facility from CRG Servicing LLC in April 2024 to fund growth initiatives, permitted acquisitions, and working capital, with $15 million drawn initially and up to $40 million more available through June 2025; enters an exclusive U.S. distribution agreement with InfuSystem Holdings Inc. for ChemoMouthpiece oral cryotherapy device in September 2024, accompanied by a $5 million investment for 6.6% ownership to expand skincare offerings for oncology patients; and reports third-quarter 2025 net revenue of $26.3 million, up 22% from the prior year, alongside expansions into virtual wound and skin care telemedicine services.
Company News
15,945 Shares of Sanara MedTech Inc. $SMTI Bought by Bank of America Corp DE
Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?
Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—FBRX, LXFR, SMTI, and MKTX
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger—FBRX, LXFR, SMTI, and MKTX
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders
Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
MIMEDX to Acquire Sanara MedTech